{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:12:21Z","timestamp":1769501541308,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.vaccine.2007.11.072","type":"journal-article","created":{"date-parts":[[2007,12,19]],"date-time":"2007-12-19T16:27:00Z","timestamp":1198081620000},"page":"614-622","source":"Crossref","is-referenced-by-count":19,"title":["Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses"],"prefix":"10.1016","volume":"26","author":[{"given":"Yongxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhang","family":"Farhangfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Hester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2007.11.072_bib1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1378\/chest.116.5.1369","article-title":"Inhalation anthrax: epidemiology, diagnosis, and management","volume":"116","author":"Shafazand","year":"1999","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.072_bib2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.072_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1286-4579(99)80004-5","article-title":"Molecular pathogenesis of Bacillus anthracis infection","volume":"1","author":"Little","year":"1999","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.072_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0891-5520(05)70050-7","article-title":"Anthrax vaccine: model of a response to the biologic warfare threat","volume":"13","author":"Nass","year":"1999","journal-title":"Infect Dis Clin North Am"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2007.11.072_bib5","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0264-410X(98)00023-1","article-title":"The effectiveness and safety of vaccines against human anthrax: a systematic review","volume":"16","author":"Demicheli","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.072_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1081\/CLT-100102886","article-title":"Use of anthrax vaccine in the United States: recommendations of the advisory committee on immunization practices","volume":"39","author":"Modlin","year":"2001","journal-title":"J Toxicol Clin Toxicol"},{"issue":"5188","key":"10.1016\/j.vaccine.2007.11.072_bib7","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.7973702","article-title":"The Sverdlovsk anthrax outbreak of 1979","volume":"266","author":"Meselson","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.072_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3201\/eid0302.970201","article-title":"The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justified?","volume":"3","author":"Kaufmann","year":"1997","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.072_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2672.1999.00901.x","article-title":"Presentation of protective antigen to the mouse immune system: immune sequelae","volume":"87","author":"Williamson","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.11.072_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MMBR.68.4.617-629.2004","article-title":"Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines","volume":"68","author":"Phipps","year":"2004","journal-title":"Microbiol Mol Biol Rev"},{"issue":"14","key":"10.1016\/j.vaccine.2007.11.072_bib11","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.vaccine.2005.12.028","article-title":"Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine","volume":"24","author":"Little","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2007.11.072_bib12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/pds.1302","article-title":"Factors influencing laboratory workers\u2019 decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program","volume":"15","author":"Fowler","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2007.11.072_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0168-1656(95)00092-5","article-title":"Development of novel vaccines against anthrax in man","volume":"44","author":"Stepanov","year":"1996","journal-title":"J Biotechnol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.072_bib14","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/IAI.68.8.4549-4558.2000","article-title":"Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax","volume":"68","author":"Cohen","year":"2000","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.072_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2672.1999.00882.x","article-title":"Bacillus anthracis surface: capsule and S-layer","volume":"87","author":"Fouet","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.072_bib16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1365-2958.1997.2941659.x","article-title":"Molecular characterization of the Bacillus anthracis main S-layer component: evidence that it is the major cell associated antigen","volume":"23","author":"Mesnage","year":"1997","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.072_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1365-2672.1999.00881.x","article-title":"The capsule of Bacillus anthracis, a review","volume":"87","author":"Ezzell","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.072_bib18","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.4049\/jimmunol.178.5.2646","article-title":"Cutting edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis","volume":"178","author":"Glomski","year":"2007","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.072_bib19","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.072_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0198-8859(97)00081-5","article-title":"Delivery of antigens to the MHC class I pathway by using bacterial toxins","volume":"54","author":"Goletz","year":"1997","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.072_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1365-2672.1999.00890.x","article-title":"Anthrax toxin fusion proteins for intracellular delivery of macromolecules","volume":"87","author":"Leppla","year":"1999","journal-title":"J Appl Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.072_bib22","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.4049\/jimmunol.159.9.4435","article-title":"Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against listeria monocytogenes","volume":"159","author":"Sirard","year":"1997","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.072_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2005.05.035","article-title":"A retrogen plasmid-based vaccine generates high titer antibody responses against the autologous cancer antigen surviving and demonstrates anti-tumor efficacy","volume":"237","author":"Decker","year":"2006","journal-title":"Cancer Lett"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.072_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.gt.3302160","article-title":"Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines","volume":"11","author":"Hauser","year":"2004","journal-title":"Gene Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.072_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1046-2023(03)00136-1","article-title":"Augmentation of DNA vaccine potency through secretory heat shock protein-mediated antigen targeting","volume":"31","author":"Hauser","year":"2003","journal-title":"Methods"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.072_bib26","first-page":"3704","article-title":"Targeting dendritic cells to enhance DNA vaccine potency","volume":"61","author":"You","year":"2001","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.072_bib27","first-page":"197","article-title":"A retrogen strategy for presentation of an intracellular tumor antigen as an exogenous antigen by dendritic cells induces potent antitumor T helper and CTL responses","volume":"61","author":"You","year":"2001","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.072_bib28","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.4049\/jimmunol.165.8.4581","article-title":"Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway","volume":"165","author":"You","year":"2000","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.11.072_bib29","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1073\/pnas.93.10.5141","article-title":"Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization","volume":"93","author":"Raz","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2007.11.072_bib30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.072_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.072_bib32","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/intimm\/dxl015","article-title":"Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS","volume":"18","author":"Duenas","year":"2006","journal-title":"Int Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2007.11.072_bib33","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1128\/JVI.76.17.8729-8736.2002","article-title":"Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling","volume":"76","author":"Bieback","year":"2002","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2007.11.072_bib34","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1016\/j.vaccine.2005.08.025","article-title":"Comparison of the immunological memory after DNA vaccination against anthrax in sheep","volume":"24","author":"Hahn","year":"2006","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2007.11.072_bib35","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1016\/j.vaccine.2005.08.031","article-title":"DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components","volume":"24","author":"Hahn","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.072_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijmm.2003.12.002","article-title":"Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination","volume":"294","author":"Hahn","year":"2004","journal-title":"Int J Med Microbiol"},{"issue":"37","key":"10.1016\/j.vaccine.2007.11.072_bib37","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2007.11.072_bib38","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","article-title":"Genetic immunization against anthrax","volume":"22","author":"Galloway","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.11.072_bib39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"issue":"5617","key":"10.1016\/j.vaccine.2007.11.072_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1082305","article-title":"Requirement for CD4 T-cell help in generating functional CD8 T-cell memory","volume":"300","author":"Shedlock","year":"2003","journal-title":"Science"},{"issue":"6925","key":"10.1016\/j.vaccine.2007.11.072_bib41","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T-cells are required for secondary expansion and memory in CD8+ T-lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07014247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07014247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T10:31:27Z","timestamp":1684146687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07014247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0264410X07014247"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}